Skip to main content
Clinical Trials/CTRI/2020/04/024847
CTRI/2020/04/024847
Not yet recruiting
未知

Multicentric trial on role of urinary biomarkers in predicting renal injury in high risk term neonates - one year follow up

International society of Nephrology0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: P84- Other problems with newborn
Sponsor
International society of Nephrology
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
International society of Nephrology

Eligibility Criteria

Inclusion Criteria

  • All high risk neonates \>36 weeks of gestation age are included.
  • High risk neonates include:
  • 1\. Those with severe sepsis (any 2 organ dysfunction) or septic shock requiring mechanical ventilation or inotropic support or coagulopathy with bleeding manifestations.
  • 2\. Those with Hypoxic Ischemic Encephalopathy stage 2 or 3 (Sarnath classification).
  • 3\. Any neonate requiring major surgical intervention
  • 4\. Hemodynamically significant congenital heart disease requiring mechanical ventilation or ionotropic support.
  • 5\. Neonates requiring nephrotoxic medications â?? aminoglycosides, NSAIDS for \>7 days.
  • 6\. Neonates with severe IUGR (birth weight \< 3 rd centile using Fenton chart) or with Doppler abnormalities.
  • 7\. Neonates with hyperbilirubinemia requiring exchange transfusion
  • 8\. Neonates with severe dehydration ( \>10% weight loss) with hypernatremia ( \>145\) with clinical features of dehydration with decreased urine output.

Exclusion Criteria

  • Neonates with major renal anomalies like Posterior Urethral Valve and any anomalies affecting both kidneys.
  • Parents who refuse to consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials